Assembly Biosciences, Inc. SEC filings ASMB
Assembly Biosciences, Inc. has 901 filings in SEC EDGAR's recent list, going back to Feb 7, 2008. Its latest annual report, Form ARS, was filed on Apr 22, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 13, 2026 (acquisition or sale of assets). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| ARS | Annual report to shareholders | Apr 22, 2026 | Dec 31, 2025 |
| 10-K | Annual report | Mar 19, 2026 | Dec 31, 2025 |
| ARS | Annual report to shareholders | Apr 23, 2025 | Dec 31, 2024 |
| 10-K | Annual report | Mar 20, 2025 | Dec 31, 2024 |
| ARS | Annual report to shareholders | Apr 17, 2024 | Dec 31, 2023 |
| 10-K | Annual report | Mar 28, 2024 | Dec 31, 2023 |
| ARS | Annual report to shareholders | Apr 12, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Mar 22, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Mar 11, 2022 | Dec 31, 2021 |
| 10-K | Annual report | Feb 25, 2021 | Dec 31, 2020 |
| 10-K | Annual report | Mar 4, 2020 | Dec 31, 2019 |
| 10-K | Annual report | Feb 28, 2019 | Dec 31, 2018 |
| 10-K | Annual report | Mar 8, 2018 | Dec 31, 2017 |
| 10-K | Annual report | Mar 2, 2017 | Dec 31, 2016 |
| 10-K | Annual report | Mar 11, 2016 | Dec 31, 2015 |
| 10-K/A | Amended annual report | Mar 16, 2015 | Dec 31, 2014 |
| 10-K | Annual report | Mar 12, 2015 | Dec 31, 2014 |
| 10-K | Annual report | Mar 31, 2014 | Dec 31, 2013 |
| 10-K | Annual report | Mar 18, 2013 | Dec 31, 2012 |
| 10-K/A | Amended annual report | Jun 13, 2012 | Dec 31, 2011 |
| 10-K | Annual report | Mar 14, 2012 | Dec 31, 2011 |
| 10-K | Annual report | Apr 13, 2011 | Dec 31, 2010 |
Showing 22 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ASMB (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- South San Francisco, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1426800
- Former names
- VENTRUS BIOSCIENCES INC (until Jul 11, 2014)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.